| Literature DB >> 8559388 |
F Valldeoriola1, F Graus, A Rimola, H Andreu, J Santamaria, A Catafau, J Visa, E Tolosa, J Rodés.
Abstract
Four liver transplant recipients treated with cyclosporine developed a reversible neurologic syndrome characterized by a speech disorder leading to mutism. This complication, previously reported in a few liver transplant recipients treated with the immunosuppressive drug FK506, had not been described with cyclosporine. Recognition of this syndrome should prompt withdrawal of the drug and avoidance of unnecessary diagnostic procedures.Entities:
Mesh：
Substances：
Year: 1996 PMID： 8559388 DOI： 10.1212/wnl.46.1.252
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910